Growth Metrics

Novartis Ag (NVS) Exchange Rate Effect (2016 - 2026)

Novartis Ag's Exchange Rate Effect history spans 12 years, with the latest figure at -$77.0 million for Q1 2026.

  • On a quarterly basis, Exchange Rate Effect fell 142.78% to -$77.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $319.0 million, a 3887.5% increase, with the full-year FY2025 number at $576.0 million, up 293.29% from a year prior.
  • Exchange Rate Effect hit -$77.0 million in Q1 2026 for Novartis Ag, down from $36.0 million in the prior quarter.
  • Over the last five years, Exchange Rate Effect for NVS hit a ceiling of $382.0 million in Q2 2025 and a floor of -$314.0 million in Q4 2024.
  • Historically, Exchange Rate Effect has averaged $15.8 million across 5 years, with a median of -$22.0 million in 2025.
  • Biggest five-year swings in Exchange Rate Effect: tumbled 3300.0% in 2024 and later surged 1223.53% in 2025.
  • Tracing NVS's Exchange Rate Effect over 5 years: stood at $141.0 million in 2022, then increased by 13.48% to $160.0 million in 2023, then plummeted by 296.25% to -$314.0 million in 2024, then soared by 111.46% to $36.0 million in 2025, then crashed by 313.89% to -$77.0 million in 2026.
  • Business Quant data shows Exchange Rate Effect for NVS at -$77.0 million in Q1 2026, $36.0 million in Q4 2025, and -$22.0 million in Q3 2025.